<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>


<title>aktiencheck.de - Forum - TALI Digital</title>
<link>http://www.aktiencheck.de</link>
<description>aktiencheck.de</description>
<language></language>
<copyright>aktiencheck.de</copyright>
<lastBuildDate>Wed, 22 Apr 2026 03:33:54 +0200</lastBuildDate>
<ttl>2</ttl>








<item>
<title>Avexa auf dem Vormarsch</title>
<link>http://www.aktiencheck.de/forum/Avexa_auf_dem_Vormarsch-A2PXRB-t234791</link>
<guid>http://www.aktiencheck.de/forum/Avexa_auf_dem_Vormarsch-A2PXRB-t234791</guid>
<description>Avexa auf dem Vormarsch, FDA Feedback and Expert Panel Review Positive for Avexa 



MELBOURNE, Australia, October 4, 2005 - Research and development biotechnology company Avexa Limited (ASX: AVX) announced that, following a meeting with the US Food and Drug Administration (FDA), it has received encouraging feedback on the development plan for its HIV/AIDS drug candidate AVX754. This places the Company in an excellent position to move rapidly into Phase III after the successful completion of its ongoing Phase IIb trial. 


 
Avexa expects to have results on the primary endpoint of its Phase IIb trial in the first quarter of calendar year 2006. 

Additionally, Avexa met with an international panel of independent, world-renowned experts in the clinical management of HIV to discuss the potential AVX754 may offer in the treatment of patients with drug-resistant HIV who are failing their current therapy. The panel also discussed the ongoing Phase IIb trial for AVX754 and the Compa [&lt;a href=&#034;http://www.aktiencheck.de/forum/Avexa_auf_dem_Vormarsch-A2PXRB-t234791&#034;&gt;mehr&lt;/a&gt;]</description>
</item>







<item>
<title>AVEXA LTD.</title>
<link>http://www.aktiencheck.de/forum/AVEXA_LTD-A2PXRB-t214049</link>
<guid>http://www.aktiencheck.de/forum/AVEXA_LTD-A2PXRB-t214049</guid>
<description>Abwarten..., Der Titel is gar net so schlecht. Der Titel schloss gestern bei www.asx.com Kürzel: AVX bei 25 Cent. Abwarten. Der läuft schon noch an. [&lt;a href=&#034;http://www.aktiencheck.de/forum/AVEXA_LTD-A2PXRB-t214049&#034;&gt;mehr&lt;/a&gt;]</description>
</item>

</channel>
</rss>







